IDEXX Labs cuts 2024 revenue forecast on lagging vet visits, strong dollar
(Reuters) - IDEXX Laboratories lowered its annual sales forecast after missing quarterly estimates on Wednesday, as the anima...
4h ago
J&J advances $6.475 billion settlement of talc cancer lawsuits
By Dietrich Knauth NEW YORK(Reuters) - Johnson & Johnson is moving forward with a $6.475 billion proposed settlement of t...
5h ago
CVS cuts 2024 profit forecast as insurance unit faces soaring medical costs
(Reuters) -CVS Health Corp slashed its annual profit forecast and missed Wall Street estimates for first-quarter earnings on ...
5h ago
Pfizer lifts 2024 profit view on cost cuts, higher COVID vaccine demand
(Reuters) -Pfizer lifted its annual profit forecast on Wednesday, banking on cost cuts and better-than-expected demand for it...
5h ago
Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
COPENHAGEN (Reuters) - Denmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing...
6h ago
Arizona Senate expected to vote on 1864 abortion ban repeal
By Brad Brooks (Reuters) - The Arizona Senate is expected to vote on Wednesday on a measure to repeal the state's 1864 ban on...
6h ago
Optomed Oyj, AEYE Health say portable device to detect eye issues gets FDA nod
(Reuters) - A portable device that detects eye conditions that can cause sight loss in people with conditions such as diabete...
6h ago
VP Harris visits Florida as abortion ban limits southern women's options
By Nandita Bose WASHINGTON (Reuters) - U.S. Vice President Kamala Harris visits Florida on Wednesday to denounce the state's ...
8h ago
UK's Smith+Nephew retains annual forecasts despite Q1 revenue miss
(Reuters) - British medical equipment maker Smith+Nephew retained its annual revenue and profit forecasts on Wednesday, despi...
9h ago
Haleon's first-quarter revenue misses expectations
(Reuters) - Consumer healthcare company Haleon's first-quarter revenue missed market estimates on Wednesday, due to retailer ...
9h ago